News

• 11 June 2021

  NHS England announces national ovarian cancer audit

  NHS England have confirmed that the future of the ovarian cancer audit is secure, with the announcement that it is one of five new cancer audits to be commissioned by the Healthcare Quality Improvement Partnership (HQIP).

  

• 11 June 2021

  What is the national ovarian cancer audit?

  With the UK’s ovarian cancer survival rates remaining some of the lowest in Europe, our Head of Public Affairs and Research looks at the game-changing announcement of a government-funded ovarian cancer audit, what this means for women with ovarian cancer, and how you helped us get there.
  

  

• 13 May 2021

  What has happened to the worlds largest ovarian cancer screening trial?

  Researchers at University College London have found that these screening approaches did not significantly reduce the chance of these women developing late stage ovarian cancer. Unfortunately, this means that these tests cannot be recommended as a screening programme for the public.

  

• 10 May 2021

  Women in Scotland gain new ovarian cancer treatment

  

• 19 March 2021

  NICE approves a new combination of treatment for women with advanced ovarian cancer

  Today the National Institute for Health and Care Excellence (NICE) has announced a new maintenance treatment option for women with HRD positive advanced ovarian cancer in England. The new treatment is a welcome addition to a growing number of targeted therapy options that will help women with advanced ovarian cancer live longer.  

  

• 01 March 2021

  It’s Ovarian Cancer Awareness Month and we’re putting the spotlight on age inequality

  Over 7,000 women are diagnosed with ovarian cancer each year, with more than a third over the age of 70. Yet, in the first of a series of reports highlighting inequalities in ovarian cancer, women over 70 are not receiving the standard of care necessary to survive ovarian cancer. 

  

• 26 February 2021

  Julia Bradbury is Ovarian Cancer Action's new charity ambassador

  On 31st January Julia presented Ovarian Cancer Action’s BBC Lifeline Appeal. In her own words, Julia explains why she has chosen to support them in her new role as charity ambassador. 

  

• 28 January 2021

  Ovarian Cancer Action's BBC Lifeline Appeal

  Getting the nation's eyes on ovarian cancer. Julia Bradbury presents Ovarian Cancer Action's BBC Lifeline Appeal.

  

• 15 January 2021

  Niraparib - the latest treatment option for women with ovarian cancer in England

  Today, women diagnosed with advanced ovarian cancer will have access to a life-extending drug called Niraparib, thanks to the National Institute for Health and Care Excellence (NICE).

  

• 14 January 2021

  New classification system “Oxford Classic” can create accurate predictions of ovarian cancer outcomes

  Ovarian Cancer Action funded researcher, Professor Ahmed Ahmed, from the University of Oxford Weatherall Institute, is already making several exciting breakthroughs with his research - in more areas than one. 

  

• 16 December 2020

  The BioIndustry Association announces 2021 charity partnership with Ovarian Cancer Action

  Ovarian Cancer Action is proud to announce that it is the BioIndustry Association’s (BIA) chosen charity partner for 2021.

  

• 30 November 2020

  Are blood tests the holy grail for early diagnosis of ovarian cancer?

  

• 27 November 2020

  Tampon Tax Fund awards Ovarian Cancer Action over £1m to tackle health inequalities

  Today the ovarian cancer audit feasibility pilot published its latest findings on the variation in ovarian cancer treatment across England - revealing significant regional differences in access to ovarian cancer treatment (particularly surgery) across the country.

  

• 25 November 2020

  Amazon Prime film release focuses on ovarian cancer, featuring Cara Delevingne

  In a first for Amazon Prime, Life in a Year is a film that focuses on a young girl with ovarian cancer. This film is particularly important because it is so rare that ovarian cancer is mentioned in the mainstream media, and even less so as a concern for younger women. 

  

• 11 November 2020

  Differences in treatment revealed in new report

  Today the ovarian cancer audit feasibility pilot published its latest findings on the variation in ovarian cancer treatment across England - revealing significant regional differences in access to ovarian cancer treatment (particularly surgery) across the country.

  

• 02 November 2020

  New research confirms the importance of CA125 blood tests in diagnosing ovarian cancer in primary care

  A team of researchers at the University of Cambridge, Manchester and Exeter are the first to provide evidence that the already established CA125 blood test for ovarian cancer is an effective diagnostic tool in the primary care setting.
  

  

• 28 October 2020

  Announcement: The Rausing Trust’s Charity Survival Fund

  

• 06 October 2020

  Remembering John Harris

  John Harris, founder of the Helene Harris Memorial Trust (HHMT) that led to the inception of Ovarian Cancer Action, has passed away. 

  

• 01 September 2020

  September is Gynaecological Cancer Awareness Month

  Help us reach the 90% of women who don’t know the four main symptoms of ovarian cancer 

  

• 21 July 2020

  We need your help to get back on track

  With our income hugely affected by COVID-19, our research is at risk. Find out how you can help.